BGMD - BG Medicine, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue1,5662,7874,073
Cost of Revenue5059561,389
Gross Profit1,0611,8312,684
Operating Expenses
Research Development1,7742,3933,735
Selling General and Administrative3,9176,80013,323
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-4,630-7,362-14,374
Income from Continuing Operations
Total Other Income/Expenses Net-51426-307
Earnings Before Interest and Taxes-5,144-7,336-14,681
Interest Expense1597281,168
Income Before Tax-5,303-8,064-15,849
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-5,303-8,064-15,849
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-5,303-8,064-15,849
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-6,958-8,064-15,849